FDA OKs Steroid Insert (Dextenza) for Postop Ocular Pain FDA OKs Steroid Insert (Dextenza) for Postop Ocular Pain

Dextenza is the first FDA-approved intracanalicular insert that delivers dexamethasone to treat ocular pain following ophthalmic surgery for up to 30 days with a single insertion.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news